These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37587830)

  • 1. Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms.
    Chopra S; Bailey NG
    Am J Clin Pathol; 2023 Dec; 160(6):566-570. PubMed ID: 37587830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
    Falini B; Martelli MP
    Am J Hematol; 2023 Mar; 98(3):481-492. PubMed ID: 36606297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of WHO-5 and ICC classifications in a series of myeloid neoplasms, considerations for hematopathologists and molecular pathologists.
    Moore ME; Williams E; Pelkey L; Courville EL
    Cancer Genet; 2024 Aug; 286-287():25-28. PubMed ID: 38964162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of the 5
    Lee C; Kim HN; Kwon JA; Yoon SY; Jeon MJ; Yu ES; Kim DS; Choi CW; Yoon J
    Ann Lab Med; 2023 Sep; 43(5):503-507. PubMed ID: 37080752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC.
    Xiao W; Nardi V; Stein E; Hasserjian RP
    J Hematol Oncol; 2024 Jul; 17(1):56. PubMed ID: 39075565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting bone marrow biopsies for myelodysplastic neoplasms and acute myeloid leukaemia incorporating WHO 5th edition and ICC 2022 classification systems: ALLG/RCPA joint committee consensus recommendations.
    Ng AP; Adams R; Tiong IS; Seymour L; Talaulikar D; Palfreyman E; Enjeti A; Tate C
    Pathology; 2024 Jun; 56(4):459-467. PubMed ID: 38580613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NGS panel enhance precise diagnosis of myeloid neoplasms under WHO-HAEM5 and International Consensus Classification: An observational study.
    Ye X; Zheng Z; Wu Y; Zhang Z; Xu Z; Liu Y; Jiang L; Wu J
    Medicine (Baltimore); 2024 Jun; 103(24):e38556. PubMed ID: 38875377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AML classification in the year 2023: How to avoid a Babylonian confusion of languages.
    Huber S; Baer C; Hutter S; Dicker F; Meggendorfer M; Pohlkamp C; Kern W; Haferlach T; Haferlach C; Hoermann G
    Leukemia; 2023 Jul; 37(7):1413-1420. PubMed ID: 37120689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid madness: assessing diagnostic inconsistency between the new WHO and ICC schemes for myelodysplastic/myeloproliferative neoplasms.
    Benton LG; Kallen ME; Jacobs JL; McCool IE; Ning Y; Duong VH; Koka R; Singh ZN
    J Clin Pathol; 2023 Dec; 77(1):68-72. PubMed ID: 37696594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new WHO and ICC classification systems for myelodysplastic syndromes and their impact on the clinical laboratory.
    Bruehl FK; Osman MM; Chen D; Dalland JC
    J Hematop; 2023 Jun; 16(2):65-71. PubMed ID: 38175439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.
    Lee WH; Lin CC; Tsai CH; Tien FM; Lo MY; Ni SC; Yao M; Tseng MH; Kuo YY; Liu MC; Tang JL; Sun HI; Chuang YK; Chou WC; Hou HA; Tien HF
    Am J Hematol; 2023 Mar; 98(3):398-407. PubMed ID: 36588411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting.
    Attardi E; Savi A; Borsellino B; Piciocchi A; Cipriani M; Ottone T; Fabiani E; Divona M; Travaglini S; Pascale MR; Awada H; Durmaz A; Visconte V; Della Porta MG; Venditti A; Maciejewski JP; Gurnari C; Voso MT
    Blood Adv; 2023 Sep; 7(17):5122-5131. PubMed ID: 37327116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new diagnostic criteria for myelodysplasia-related acute myeloid leukemia is useful for predicting clinical outcome: comparison of the 4th and 5th World Health Organization classifications.
    Park HS; Kim HK; Kim HS; Yang Y; Han HS; Lee KH; Son BR; Kwon J
    Ann Hematol; 2022 Dec; 101(12):2645-2654. PubMed ID: 36220882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of flow cytometry in the classification of myeloid disorders.
    Saft L
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):164-175. PubMed ID: 37991530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances towards genome-based acute myeloid leukemia classification: A comparative analysis of WHO-HAEM4R, WHO-HAEM5, and International Consensus Classification.
    Chen X; Yuan L; Zhang Y; Wang F; Ma X; Fang J; Cao P; Liu Y; Liu Z; Liu M; Chen J; Zhou X; Liu M; Jin D; Wang T; Lu P; Liu H
    Am J Hematol; 2024 May; 99(5):824-835. PubMed ID: 38321864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the International Consensus Classification of myelodysplastic syndromes.
    Zhang Y; Wu J; Xu Z; Qin T; Qu S; Pan L; Wang H; Sun Q; Li C; Jia Y; Cai W; Yan X; Gong J; Gao Q; Li B; Gale RP; Xiao Z
    Br J Haematol; 2023 May; 201(3):443-448. PubMed ID: 36575970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Precision or Pitfalls: How to Apply the New Acute Myeloid Leukemia Classification Systems?
    Carlson KS; Cunningham A; Stahl M; Winer E; Michaelis LC
    Acta Haematol; 2024; 147(2):122-132. PubMed ID: 38071966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The International Consensus Classification of myelodysplastic syndromes and related entities.
    Hasserjian RP; Orazi A; Orfao A; Rozman M; Wang SA
    Virchows Arch; 2023 Jan; 482(1):39-51. PubMed ID: 36287260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
    Vardiman JW
    Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.